» Articles » PMID: 29066859

Epiretinal Membrane and Cystoid Macular Edema As Predictive Factors of Recurrent Proliferative Vitreoretinopathy

Overview
Journal Clin Ophthalmol
Publisher Dove Medical Press
Specialty Ophthalmology
Date 2017 Oct 26
PMID 29066859
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Proliferative vitreoretinopathy (PVR) is the most common cause of recurrent retinal detachment (RD). We sought to determine the predictive factors of recurrent PVR formation and the need for additional vitreoretinal surgical intervention after uncomplicated primary RD repair.

Methods: This is a retrospective single-center case-control study of consecutive patients with PVR formation after uncomplicated RD repair. Logistic regression was used to assess factors associated with recurrent PVR formation.

Results: Thirty-seven eyes (37 patients) who had recurrent RD secondary to PVR formation were included. Among those, 27 eyes needed one additional surgery, whereas the remainder 10 eyes required two or more additional surgeries. In the univariate analysis, patients who had cystoid macular edema (CME) after the second surgery were 8.33 times (crude odds ratio [COR], 95% confidence interval [CI]: 1.23-56.67, =0.0302) more likely to have recurrent PVR formation compared to those who did not have CME after the second surgery. Similarly, those who had epiretinal membrane (ERM) after the second surgery were 8.00 times (COR, 95% CI: 1.43-44.92, =0.0182) more likely to have recurrent PVR formation compared to those who did not have ERM after the second surgery. In the multivariate analysis, patients who had ERM after the second surgery were 8.20 times (adjusted odds ratio [AOR], 95% CI: 1.08-62.40, =0.0422) more likely to develop recurrent PVR compared to those who did not have ERM after the second surgery, when adjusted for age, sex, and CME after the second surgery.

Conclusion: ERM and CME are potential predictive factors for recurrent PVR formation after uncomplicated primary RD repair. Early recognition and treatment of ERM and CME may be critical to prevent subsequent PVR formation and improve visual outcomes.

Citing Articles

Retinal redetachment after silicone oil removal: a risk factor analysis.

Gisquet C, Ndiaye N, Dubroux C, Angioi-Duprez K, Berrod J, Conart J BMC Ophthalmol. 2024; 24(1):346.

PMID: 39148018 PMC: 11325823. DOI: 10.1186/s12886-024-03618-z.


Vitrectomy with Silicone Oil Tamponade and Single-Dose Intravitreal Methotrexate for Recurrent Retinal Detachment with Proliferative Vitreoretinopathy.

Babel A, Chin E, Almeida D Case Rep Ophthalmol. 2023; 13(3):777-782.

PMID: 36845445 PMC: 9944208. DOI: 10.1159/000526091.


Pars Plana Vitrectomy Outcomes for Rhegmatogenous Retinal Detachment Qualifying for Pneumatic Retinopexy.

Kurochkin P, Huang N, Petrela R, Rosenberg K, Brown J, Oellers P Clin Ophthalmol. 2021; 15:1207-1214.

PMID: 33776417 PMC: 7989046. DOI: 10.2147/OPTH.S302413.

References
1.
Campochiaro P . Pathogenic mechanisms in proliferative vitreoretinopathy. Arch Ophthalmol. 1997; 115(2):237-41. DOI: 10.1001/archopht.1997.01100150239014. View

2.
Hiscott P, Wong D, Grierson I . Challenges in ophthalmic pathology: the vitreoretinal membrane biopsy. Eye (Lond). 2000; 14 ( Pt 4):549-59. DOI: 10.1038/eye.2000.142. View

3.
Rothova A . Inflammatory cystoid macular edema. Curr Opin Ophthalmol. 2007; 18(6):487-92. DOI: 10.1097/ICU.0b013e3282f03d2e. View

4.
Bringmann A, Wiedemann P . Involvement of Müller glial cells in epiretinal membrane formation. Graefes Arch Clin Exp Ophthalmol. 2009; 247(7):865-83. DOI: 10.1007/s00417-009-1082-x. View

5.
Pastor J . Proliferative vitreoretinopathy: an overview. Surv Ophthalmol. 1998; 43(1):3-18. DOI: 10.1016/s0039-6257(98)00023-x. View